Infertility Clinical Trial
Official title:
Benefits of Walnuts for Male Reproductive Health
Walnuts as a whole food contain polyunsaturated fatty acids, anti-oxidants, and other nutrients essential to sperm development and function. This randomized controlled trial sought to determine if a Western style diet supplemented with walnuts would improve sperm quality as a predictor of male fertility.
A vast research base on human sperm shows the following to be critical for normal sperm
development and function: Polyunsaturated fatty acids provide fluidity to sperm membranes
allowing sperm to swim, fuse with ova, and support key cellular functions. Antioxidants
protect sperm from reactive oxygen species generated during normal physiologic processes or
white blood cells that infiltrate into seminal fluid and injure membranes and fragment sperm
DNA. Selenium is critical in the form of anti-oxidant selenoproteins protecting developing
sperm in the testes and later selenium in the epididymis participates in cell shape for
motility. Folate, in a recent study, was associated with decreased aneuploidy (abnormal
number of chromosomes)in sperm. Deficiency in any of these factors - lipids, antioxidants,
selenium, or folate could manifest as poor semen quality and sub-fertility.
Walnuts provide a rich dietary source of each of the critical factors discussed above.
Walnuts contain beneficial lipids, antioxidants, selenium, and folate. Walnuts, as a natural
whole food source, may be preferential to commercial supplements and, as a plant source of
nutrients, leave a positive green footprint on the planet.
Hypothesis The investigators hypothesize that diets enriched in walnuts will improve semen
quality. Semen quality is a predictive marker for male infertility and sub-fertility, thus,
the overall goal is to determine if dietary intake of walnuts will benefit male reproductive
health.
A randomized, controlled intervention will be used to study the effects of walnut
supplementation on semen quality measures in young men (ages 21 to 35) eating Western diets.
Participants will be enrolled from the West Los Angeles area (n=120). Men will be randomly
assigned to consume 3 oz of walnuts per day as part of their usual diet or to continue their
habitual diet but avoid nuts. Each will follow the assigned diet for three months to cover
one complete cycle of spermatogenesis.
The specific aims of the study are to:
1. Establish at baseline: habitual diet; serum omega-3 to omega-6 ratio, serum selenium
and folate; semen quality (sperm count, motility, morphology) and sperm DNA integrity
(COMET assay); sperm aneuploidy; and semen anti-oxidant levels
2. Randomly assign men to habitual diet plus 3 oz walnuts per day or usual diet without
nuts for three months monitored by six telephone 24 hour dietary recalls
3. Compare intervention and control groups at three months on blood and semen measures
4. Compare blood and semen measures within man between baseline and three months.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03607409 -
Role of Inhibin A as Biomarker for Ovarian Response for IVF Treatment
|
||
Recruiting |
NCT02312076 -
GnRHa for Luteal Phase Support in Long GnRHa Protocol Cycles
|
Phase 4 | |
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Completed |
NCT03287479 -
Comparison of a Semi-automated Closed Vitrification System (Gavi®) With a Manual Open Vitrification Sytem (Cryotop®)
|
N/A | |
Terminated |
NCT03522350 -
Randomized Trial Comparing EmbryoScope With EmbryoScope+.
|
N/A | |
Completed |
NCT04496284 -
Embryo Transfer Outcomes After Vitrification With Slush Nitrogen Compared to Liquid Nitrogen
|
N/A | |
Completed |
NCT03623659 -
pArtiaL zonA pelluciDa Removal by assisteD hatchINg of Blastocysts
|
N/A | |
Completed |
NCT03895099 -
New Ovarian Stimulation With Random Start, Use of Progestin Protocol for Oocyte Donors
|
Phase 3 | |
Active, not recruiting |
NCT04142112 -
Randomized, Standard-Controlled, Study to Evaluate the Ohana IVF Sperm Preparation Kit, SPeRtility IVF Next Generation
|
N/A | |
Completed |
NCT03152643 -
Cumulative Live Birth Rates After Cleavage-stage Versus Blastocyst-stage Embryo Transfer
|
N/A | |
Recruiting |
NCT03683771 -
Assessment of Endometrial Pattern and Sub-endometrial Vascularity in ICSI Outcome
|
||
Recruiting |
NCT03161119 -
Comparing Two Different Embryo Transfer Catheters
|
N/A | |
Completed |
NCT04108039 -
Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles.
|
N/A | |
Completed |
NCT03678610 -
Handling Medium for ICSI With Ionomycin and Latrunculin A
|
N/A | |
Completed |
NCT03678584 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Chaetoglobosin A ( ICSI-CA)
|
N/A | |
Completed |
NCT03677492 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Cytochalasin D ( ICSI-CD)
|
N/A | |
Completed |
NCT03678558 -
Oocyte Vitrification Aided With Cytochalasin B
|
N/A | |
Completed |
NCT03678571 -
Oocyte Vitrification Aided With Latrunculin A
|
N/A | |
Completed |
NCT03678597 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin B ( ICSI-LB)
|
N/A | |
Completed |
NCT03678818 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin A (ICSI-LA)
|
N/A |